Results 251 to 260 of about 5,455,171 (343)
Objective To evaluate the real‐world safety and efficacy for standard surgical risk patients with extracranial internal carotid artery disease undergoing transcarotid artery revascularization. Methods ROADSTER 3 is a prospective, multicenter, single‐arm post‐approval study.
Jeffrey Jim +15 more
wiley +1 more source
Provider and Patient Satisfaction with Telemedicine Voice Therapy During the COVID-19 Pandemic. [PDF]
Kim ME +5 more
europepmc +1 more source
Response to Letter to the Editor: Voice Therapy in the Context of the COVID-19 Pandemic: Guidelines for Clinical Practice. [PDF]
europepmc +1 more source
Objective Despite the availability of biologic and targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) to treat rheumatoid arthritis (RA), many patients do not experience optimized disease control. Glucocorticoids are effective but have safety risks.
Frank Buttgereit +13 more
wiley +1 more source
Voices of family- and partner-violent adults in treatment : participants' experience of therapy
Justin Butler
openalex +1 more source
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane +33 more
wiley +1 more source
Effectiveness of Voice Therapy in Organic and Functional Voice Disorders [PDF]
Sibel Yıldırım +2 more
openalex +1 more source
Objective To assess whether a panel of peripheral blood biomarkers associated with idiopathic pulmonary fibrosis (IPF) is also associated with interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) utilizing three independent cohorts.
Brent A. Luedders +18 more
wiley +1 more source

